Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.
about
Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsCell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704.Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging.
P2860
Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Clinical implications of misma ...... hylation in pancreatic cancer.
@en
Clinical implications of misma ...... hylation in pancreatic cancer.
@nl
type
label
Clinical implications of misma ...... hylation in pancreatic cancer.
@en
Clinical implications of misma ...... hylation in pancreatic cancer.
@nl
prefLabel
Clinical implications of misma ...... hylation in pancreatic cancer.
@en
Clinical implications of misma ...... hylation in pancreatic cancer.
@nl
P2860
P1433
P1476
Clinical implications of misma ...... hylation in pancreatic cancer.
@en
P2860
P2888
P304
P356
10.1007/S12032-011-9968-Y
P577
2011-06-10T00:00:00Z